The University Hospital of Düsseldorf is located in the south of Düsseldorf, the state capital of the German state of North Rhine-Westphalia and center of the populous Rhine-Ruhr metropolitan region. It treats approximately 45,000 inpatients and 300,000 outpatients every year in 32 clinics and 34 institutes.

During the past decade, University Hospital Düsseldorf, Division of Cardiology, Pulmonary Disease and Vascular Medicine conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Düsseldorf, Division of Cardiology, Pulmonary Disease and Vascular Medicine" #1 collaborator was "Charite University, Berlin, Germany" with 1 trials as a collaborator, "Heart Center Leipzig - University Hospital" with 1 trials as a collaborator, "IHF GmbH - Institut für Herzinfarktforschung" with 1 trials as a collaborator, "Klinikum Ludwigshafen" with 1 trials as a collaborator and "Leipzig Heart Institute GmbH" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Düsseldorf, Division of Cardiology, Pulmonary Disease and Vascular Medicine" are "Chronic Obstructive Pulmonary Disease" (2 trials), "Aortic Aneurysm" (1 trials), "Aortic Disease" (1 trials), "Aortic Stenosis" (1 trials) and "Large Artery Stiffness" (1 trials). Many other conditions were trialed in "University Hospital Düsseldorf, Division of Cardiology, Pulmonary Disease and Vascular Medicine" in a lesser frequency.

Most popular intervention types in "University Hospital Düsseldorf, Division of Cardiology, Pulmonary Disease and Vascular Medicine" are "Other" (3 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Alectinib" (1 trials), "Atezolizumab" (1 trials), "Bevacizumab" (1 trials), "Carboplatin" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Düsseldorf, Division of Cardiology, Pulmonary Disease and Vascular Medicine" are 5 trials for "All" genders.

Currently, there are NaN active trials in "University Hospital Düsseldorf, Division of Cardiology, Pulmonary Disease and Vascular Medicine". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in University Hospital Düsseldorf, Division of Cardiology, Pulmonary Disease and Vascular Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Düsseldorf, Division of Cardiology, Pulmonary Disease and Vascular Medicine, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".